PortfoliosLab logoPortfoliosLab logo
PSG.DE vs. ARCC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PSG.DE vs. ARCC - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in PharmaSGP Holding SE (PSG.DE) and Ares Capital Corporation (ARCC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

PSG.DE is traded in EUR, while ARCC is traded in USD. To make them comparable, the ARCC values have been converted to EUR using the latest available exchange rates.

Returns By Period


PSG.DE

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

ARCC

1D
0.21%
1M
0.00%
YTD
-2.71%
6M
-5.02%
1Y
-6.61%
3Y*
6.64%
5Y*
9.95%
10Y*
12.48%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PSG.DE vs. ARCC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
PSG.DE
PharmaSGP Holding SE
0.00%15.40%18.09%-13.86%9.74%-5.00%-24.64%
ARCC
Ares Capital Corporation
-2.71%-10.93%27.68%16.43%2.12%46.32%9.57%

Correlation

The correlation between PSG.DE and ARCC is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (3Y)
Calculated over the trailing 3-year period

-0.02

Correlation (5Y)
Calculated over the trailing 5-year period

-0.03

Correlation (All Time)
Calculated using the full available price history since Jun 22, 2020

-0.01

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PSG.DE vs. ARCC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSG.DE

ARCC
ARCC Risk / Return Rank: 2727
Overall Rank
ARCC Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
ARCC Sortino Ratio Rank: 2323
Sortino Ratio Rank
ARCC Omega Ratio Rank: 2424
Omega Ratio Rank
ARCC Calmar Ratio Rank: 3131
Calmar Ratio Rank
ARCC Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PSG.DE vs. ARCC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PharmaSGP Holding SE (PSG.DE) and Ares Capital Corporation (ARCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

PSG.DE vs. ARCC - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


PSG.DEARCCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.34

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.49

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.48

Sharpe Ratio (All Time)

Calculated using the full available price history

0.40

Drawdowns

PSG.DE vs. ARCC - Drawdown Comparison


Loading charts...

Drawdown Indicators


PSG.DEARCCDifference

Max Drawdown

Largest peak-to-trough decline

-74.60%

Max Drawdown (1Y)

Largest decline over 1 year

-18.74%

Max Drawdown (3Y)

Largest decline over 3 years

-25.98%

Max Drawdown (5Y)

Largest decline over 5 years

-25.98%

Max Drawdown (10Y)

Largest decline over 10 years

-56.16%

Current Drawdown

Current decline from peak

-20.38%

Average Drawdown

Average peak-to-trough decline

-10.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.07%

Volatility

PSG.DE vs. ARCC - Volatility Comparison


Loading charts...

Volatility by Period


PSG.DEARCCDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.83%

Volatility (6M)

Calculated over the trailing 6-month period

15.12%

Volatility (1Y)

Calculated over the trailing 1-year period

19.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.37%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.02%

Dividends

PSG.DE vs. ARCC - Dividend Comparison

PSG.DE's dividend yield for the trailing twelve months is around 0.17%, less than ARCC's 10.22% yield.


PositionTTM20252024202320222021202020192018201720162015
ARCC
Ares Capital Corporation
10.22%9.49%8.77%9.59%10.12%7.65%9.47%9.01%9.88%9.67%9.22%11.02%
PSG.DE
PharmaSGP Holding SE
0.17%0.17%5.44%2.18%1.69%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PSG.DE vs. ARCC - Financials Comparison

This section allows you to compare key financial metrics between PharmaSGP Holding SE and Ares Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. PSG.DE values in EUR, ARCC values in USD

Frequently Asked Questions


PSG.DE and ARCC have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for PSG.DE and ARCC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer